Cargando…
Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China
The 3(rd) International Conference for Cancer Metabolism and Therapy was successfully held at the South Hospital Conference Center of Shanghai First People's Hospital, nearly 200 international experts from the field of cancer metabolism and therapy and about two thousand local scientists attend...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028465/ https://www.ncbi.nlm.nih.gov/pubmed/32049950 http://dx.doi.org/10.1097/MPA.0000000000001482 |
_version_ | 1783499015679115264 |
---|---|
author | Xiao, Gary Guishan Zhang, Zhigang Lu, Bin Wang, Hongyang Fan, Teresa WM Boros, László G. Gao, Ping Pan, Yue Go, Vay Liang W. |
author_facet | Xiao, Gary Guishan Zhang, Zhigang Lu, Bin Wang, Hongyang Fan, Teresa WM Boros, László G. Gao, Ping Pan, Yue Go, Vay Liang W. |
author_sort | Xiao, Gary Guishan |
collection | PubMed |
description | The 3(rd) International Conference for Cancer Metabolism and Therapy was successfully held at the South Hospital Conference Center of Shanghai First People's Hospital, nearly 200 international experts from the field of cancer metabolism and therapy and about two thousand local scientists attended the conference. The conference was sponsored by the Yangtze River Delta City Group Hospital Synergistic Development Strategic Alliance, the China Anti-Cancer Association Cancer Metabolism Professional Committee, the Chinese Association for Cancer Metabolism and Therapy under Chinese Medical Doctoral Association-Clinical Precision Medicine, and co-organized by the First People's Hospital Affiliated to Shanghai Jiaotong University, and Shanghai Jiao Tong University School of Basic Medicine Undertake, Translational Medicine Network, Shanghai Anti-Cancer Association Youth Council, Fudan University Affiliated Tumor Hospital, University of California, Los Angeles, Agi Hirshberg Center for Pancreatic Diseases and Hirshberg Foundation for Pancreatic Cancer Research, Dalian University of Technology, New York-Presbyterian, American Cancer Research Association (AACR). The theme of the conference was "Inheritance, Innovation, Excellence, Leading" and its aim is to create a high-end academic exchange platform to discuss new technologies, new methods, and new products in tumor metabolism, tumor immunity, tumor markers and other fields. The conference involves cancer metabolism reprogramming, metabolism and tumor microenvironment, lipid metabolism, non-metabolic function of metabolic enzymes, metabolism and epigenetics, clinical transformation, new technologies for tumor immunotherapy, clinical application of tumor immunotherapy, emerging targeted therapy, PD-1/PD-L1 technology, CAR-T technology, novel tumor protein markers, novel tumor methylation markers, ctDNA, CTC, etc. The meeting ended in a lively discussion among scientists from different levels who truly benefit from the sessions about cancer metabolism and treatment. The next meeting is planned to be held October 2 through October 6, 2019 in Los Angeles, Calif. The meeting venue will be announced accordingly in the meeting web site (www.cmt.org). |
format | Online Article Text |
id | pubmed-7028465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-70284652020-03-10 Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China Xiao, Gary Guishan Zhang, Zhigang Lu, Bin Wang, Hongyang Fan, Teresa WM Boros, László G. Gao, Ping Pan, Yue Go, Vay Liang W. Pancreas Conference Report The 3(rd) International Conference for Cancer Metabolism and Therapy was successfully held at the South Hospital Conference Center of Shanghai First People's Hospital, nearly 200 international experts from the field of cancer metabolism and therapy and about two thousand local scientists attended the conference. The conference was sponsored by the Yangtze River Delta City Group Hospital Synergistic Development Strategic Alliance, the China Anti-Cancer Association Cancer Metabolism Professional Committee, the Chinese Association for Cancer Metabolism and Therapy under Chinese Medical Doctoral Association-Clinical Precision Medicine, and co-organized by the First People's Hospital Affiliated to Shanghai Jiaotong University, and Shanghai Jiao Tong University School of Basic Medicine Undertake, Translational Medicine Network, Shanghai Anti-Cancer Association Youth Council, Fudan University Affiliated Tumor Hospital, University of California, Los Angeles, Agi Hirshberg Center for Pancreatic Diseases and Hirshberg Foundation for Pancreatic Cancer Research, Dalian University of Technology, New York-Presbyterian, American Cancer Research Association (AACR). The theme of the conference was "Inheritance, Innovation, Excellence, Leading" and its aim is to create a high-end academic exchange platform to discuss new technologies, new methods, and new products in tumor metabolism, tumor immunity, tumor markers and other fields. The conference involves cancer metabolism reprogramming, metabolism and tumor microenvironment, lipid metabolism, non-metabolic function of metabolic enzymes, metabolism and epigenetics, clinical transformation, new technologies for tumor immunotherapy, clinical application of tumor immunotherapy, emerging targeted therapy, PD-1/PD-L1 technology, CAR-T technology, novel tumor protein markers, novel tumor methylation markers, ctDNA, CTC, etc. The meeting ended in a lively discussion among scientists from different levels who truly benefit from the sessions about cancer metabolism and treatment. The next meeting is planned to be held October 2 through October 6, 2019 in Los Angeles, Calif. The meeting venue will be announced accordingly in the meeting web site (www.cmt.org). Lippincott Williams & Wilkins 2020-02 2020-02-12 /pmc/articles/PMC7028465/ /pubmed/32049950 http://dx.doi.org/10.1097/MPA.0000000000001482 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Conference Report Xiao, Gary Guishan Zhang, Zhigang Lu, Bin Wang, Hongyang Fan, Teresa WM Boros, László G. Gao, Ping Pan, Yue Go, Vay Liang W. Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China |
title | Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China |
title_full | Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China |
title_fullStr | Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China |
title_full_unstemmed | Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China |
title_short | Proceedings of the 3(rd) International Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China |
title_sort | proceedings of the 3(rd) international conference for cancer metabolism and therapy, october 12–14, 2018, shanghai, china |
topic | Conference Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028465/ https://www.ncbi.nlm.nih.gov/pubmed/32049950 http://dx.doi.org/10.1097/MPA.0000000000001482 |
work_keys_str_mv | AT xiaogaryguishan proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT zhangzhigang proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT lubin proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT wanghongyang proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT fanteresawm proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT boroslaszlog proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT gaoping proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT panyue proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina AT govayliangw proceedingsofthe3rdinternationalconferenceforcancermetabolismandtherapyoctober12142018shanghaichina |